Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). (Q45013248)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). |
scientific article |
Statements
1 reference
Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). (English)
1 reference
Christopher Nelson
1 reference
Darrell Rigel
1 reference
Stacy Smith
1 reference
Neil Swanson
1 reference
John Wolf
1 reference
1 July 2004
1 reference
1 reference
3
1 reference
4
1 reference
401-407
1 reference
Identifiers
1 reference